Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
Глобальные тенденции легочных инфекций, вызванных нетуберкулезными микобактериями: систематический обзор
2022-10-13
SCID: 54.1/5sdvn2dh
Discuss with AI
Mycobacterium abscessus complexMycobacterium avium complexincidence and prevalence trendspulmonary nontuberculous mycobacteriasystematic review
Figures from the paper
Abstract (AI)
OBJECTIVES: To describe the global trends of pulmonary nontuberculous mycobacteria (NTM) infection and disease. METHODS: A systematic review of studies including culture-based NTM data over time. Studies reporting on pulmonary NTM infection and/or disease were included. Information on the use of guideline-based criteria for disease were collected, in which, infection is defined as the absence of symptoms and radiological findings compatible with NTM pulmonary disease. The trends of change for incidence/prevalence were evaluated using linear regressions, and the corresponding pooled estimates were calculated. RESULTS: Most studies reported increasing pulmonary NTM infection (82.1%) and disease (66.7%) trends. The overall annual rate of change for NTM infection and disease per 100,000 persons/year was 4.0% (95% confidence interval [CI]: 3.2-4.8) and 4.1% (95% CI: 3.2-5.0), respectively. For absolute numbers of NTM infection and disease, the overall annual change was 2.0 (95% CI: 1.6-2.3) and 0.5 (95% CI: 0.3-0.7), respectively. An increasing trend was also seen for Mycobacterium avium complex infection (n = 15/19, 78.9%) and disease (n = 10/12, 83.9%) and for Mycobacterium abscessus complex (n = 15/23, 65.2%) infection (n = 11/17, 64.7%) but less so for disease (n = 2/8, 25.0%). CONCLUSION: Our data indicate an overall increase in NTM worldwide for both infection and disease. The explanation to this phenomenon warrants further investigation.
Key Findings
1
Absolute pulmonary NTM infection and disease increased annually by 2.0 and 0.5 cases per 100,000 persons, respectively.
2
Most included studies reported increasing trends in pulmonary NTM infection (82.1%) and disease (66.7%) worldwide.
3
Mycobacterium avium complex showed predominantly increasing trends for both infection and disease, while Mycobacterium abscessus complex increases were more consistent for infection than disease.
4
The observed worldwide increase in pulmonary NTM infection and disease requires further investigation to determine its underlying causes.
5
The pooled annual rate of change was 4.0% for NTM infection and 4.1% for NTM disease per 100,000 persons per year.
Research Object
Global pulmonary infections and diseases caused by nontuberculous mycobacteria (NTM), including Mycobacterium avium complex and Mycobacterium abscessus complex
Research Subject
Global temporal trends and annual changes in the incidence and prevalence of pulmonary NTM infection and disease
Publication Details
Publication Date
2022-10-13
Journal
Publisher
ISSN
Cited by
367
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials2011
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Cited by4
Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects2024
A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges2023
Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review2024
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic review2026